Month: September 2020

New results published in the journal Biofabrication may help researchers on their quest to regenerate vascularized tissues. 

On this week's episode of Lifespan News, Brent Nally talks about an epigenetic clock for cats, accelerated epigenetic aging in athletes, a two-pronged approach to bone repair, caloric restriction benefiting DNA repair in mice, and a new research center to study aging.

A group of researchers have devised an effective anti-cancer therapy by loading cytokine-coding RNA fragments into lipid nanoparticles and injecting them directly into the tumor [1]. Anti-cancer immunotherapy is a powerful novel strategy that has given hope to millions of cancer patients. The immune system has a few aces up its sleeve when fighting cancer,...

Researchers have published a new animal study showing that the plant flavonoid naringenin may be useful in targeting problematic senescent cells in the brain. Ribes meyeri (also known as Ribes meyeri maxim) is a native plant to central Asia, Mongolia and Northeast Afghanistan and is part of the Saxifragaceae family and the Ribes genus; this...

Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a broad-spectrum antiviral that has the potential to destroy a wide range of viruses. Its drug, known as VTose, is a variant of an older antiviral drug known as DRACO, which unfortunately failed to gain sufficient funding a...

Dr. Oliver Medvedik and the Journal Club will be returning on September 30th at 1:00 PM EDT live on our Facebook page. The topic for this month is going to be a new study that implicates an innate immune inflammatory protein in disease progression using mouse models. Innate immunity is associated with Alzheimer's disease, but...